Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
SeaStar Medical Holding Corp (NASDAQ: ICU) closed the day trading at $0.62 up 9.47% from the previous closing price of $0.57. In other words, the price has increased by $9.47 from its previous closing price. On the day, 3.78 million shares were traded. ICU stock price reached its highest trading level at $0.65 during the session, while it also had its lowest trading level at $0.5576.
Ratios:
For a better understanding of ICU, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’25 when Van Heel Kenneth bought 25,000 shares for $0.89 per share. The transaction valued at 22,248 led to the insider holds 39,400 shares of the business.
Van Heel Kenneth bought 10,000 shares of ICU for $8,565 on Aug 27 ’25. The Director now owns 49,400 shares after completing the transaction at $0.86 per share. On Aug 22 ’25, another insider, Chung Kevin, who serves as the Chief Medical Officer of the company, bought 10,000 shares for $0.80 each. As a result, the insider paid 8,000 and bolstered with 58,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 17418708 and an Enterprise Value of 11116708. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.62 while its Price-to-Book (P/B) ratio in mrq is 3.24. Its current Enterprise Value per Revenue stands at 14.513.
Stock Price History:
The Beta on a monthly basis for ICU is -1.04, which has changed by -0.8671329 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $4.38, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is -22.96%, while the 200-Day Moving Average is calculated to be -52.02%.
Shares Statistics:
Over the past 3-months, ICU traded about 3.65M shares per day on average, while over the past 10 days, ICU traded about 5558460 shares per day. A total of 27.91M shares are outstanding, with a floating share count of 27.57M. Insiders hold about 1.25% of the company’s shares, while institutions hold 1.73% stake in the company. Shares short for ICU as of 1757894400 were 4471307 with a Short Ratio of 1.22, compared to 1755216000 on 1597304. Therefore, it implies a Short% of Shares Outstanding of 4471307 and a Short% of Float of 16.09.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of SeaStar Medical Holding Corp (ICU) in the stock market.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.72 and -$0.72 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.45, with 1.0 analysts recommending between -$0.45 and -$0.45.
Revenue Estimates
1 analysts predict $250k in revenue for. The current quarter. It ranges from a high estimate of $250k to a low estimate of $250k. As of. The current estimate, SeaStar Medical Holding Corp’s year-ago sales were $68kFor the next quarter, 1 analysts are estimating revenue of $350k. There is a high estimate of $350k for the next quarter, whereas the lowest estimate is $350k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.23M, while the lowest revenue estimate was $1.23M, resulting in an average revenue estimate of $1.23M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $2.01M in the next fiscal year. The high estimate is $2.01M and the low estimate is $2.01M.
